IGF-1 LR3

IGF-1 LR3 1MG

Manufacturer: GetVital
Package: 1 mg/vial
Common Names: IGF-1 LR3, IGF-1 Long R3, Long R3 IGF-1, Insulin-like Growth Factor-1 LR3, Long-Arg3-IGF-1

Info: IGF-1 LR3 (Insulin-like Growth Factor-1 Long R3) is a synthetic analog of insulin-like growth factor-1 (IGF-1) that has been structurally modified to extend its activity compared with endogenous IGF-1. It has been investigated for its interaction with IGF-1 receptors and its involvement in signaling pathways associated with cellular growth, differentiation, protein synthesis, and metabolic regulation. 

Effects

IGF-1 Receptor Research: IGF-1 LR3 has been studied for its ability to interact with IGF-1 receptors and activate intracellular signaling pathways involved in cellular growth, differentiation, and protein metabolism. Its modified structure allows researchers to investigate prolonged IGF-1-related activity compared with native IGF-1.

Dosage Range and Duration of Use

IGF-1 LR3 1 mg (1 mg/vial): Each vial contains 1 mg of IGF-1 LR3 in lyophilized form and requires appropriate preparation using sterile procedures before administration.

In research and experimental settings, subcutaneous or intramuscular administration typically ranges from 20 mcg to 50 mcg per day, with advanced protocols occasionally reaching up to 80 mcg daily. Due to its extended half-life compared to native IGF-1, it is usually administered once per day or on workout days only. Standard experimental cycles generally last between 4 to 6 weeks, followed by an equivalent break to prevent receptor desensitization and ensure proper evaluation under professional guidance.

Side Effects

The complete safety profile of IGF-1 LR3 has not been established for all routes of administration and research applications. Potential reactions may vary according to dosage, exposure, administration method, individual characteristics, and concurrent substances. Possible reactions may include injection-site irritation, redness, swelling, headache, dizziness, fatigue, changes in fluid balance, and metabolic effects associated with glucose regulation.

Post-Cycle Therapy

IGF-1 LR3 is a peptide growth-factor analog and is not an anabolic steroid, androgenic compound, or testosterone-suppressing anabolic agent. It therefore does not require conventional post-cycle therapy (PCT) protocols associated with anabolic steroid use. As a research compound that interacts with IGF-1 signaling pathways, its use should nevertheless remain within an appropriate medical or scientific framework.

Storage:

Store lyophilized IGF-1 LR3 according to the manufacturer's storage specifications and protect the vial from excessive heat, moisture, and direct exposure to light. After reconstitution, storage requirements and stability may depend on the diluent, concentration, preparation method, and manufacturer's instructions.